Sleep and behavior in children and adolescents with tuberous sclerosis complex
暂无分享,去创建一个
A. Vignoli | M. Canevini | E. Zambrelli | K. Turner | F. La Briola | A. Peron | A. Leidi
[1] A. Vignoli,et al. Sleep disturbances in Italian children and adolescents with epilepsy: A questionnaire study , 2020, Epilepsy & Behavior.
[2] N. Rensing,et al. Hypothalamic orexin and mechanistic target of rapamycin activation mediate sleep dysfunction in a mouse model of tuberous sclerosis complex , 2020, Neurobiology of Disease.
[3] M. Jaatun,et al. TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study , 2018, Orphanet Journal of Rare Diseases.
[4] D. Pearson,et al. A clinical update on tuberous sclerosis complex‐associated neuropsychiatric disorders (TAND) , 2018, American journal of medical genetics. Part C, Seminars in medical genetics.
[5] A. Vignoli,et al. Deep phenotyping of patients with Tuberous Sclerosis Complex and no mutation identified in TSC1 and TSC2. , 2018, European journal of medical genetics.
[6] C. Oliver,et al. A cross-syndrome cohort comparison of sleep disturbance in children with Smith-Magenis syndrome, Angelman syndrome, autism spectrum disorder and tuberous sclerosis complex , 2018, Journal of Neurodevelopmental Disorders.
[7] J. Lipton,et al. Aberrant Proteostasis of BMAL1 Underlies Circadian Abnormalities in a Paradigmatic mTOR-opathy. , 2017, Cell reports.
[8] P. J. Vries,et al. Neurological and neuropsychiatric aspects of tuberous sclerosis complex , 2015, The Lancet Neurology.
[9] T. Güttler,et al. The Circadian Protein BMAL1 Regulates Translation in Response to S6K1-Mediated Phosphorylation , 2015, Cell.
[10] P. D. de Vries,et al. Advances in the treatment of tuberous sclerosis complex , 2015, Current opinion in psychiatry.
[11] E. Roach,et al. Tuberous sclerosis complex. , 2015, Handbook of clinical neurology.
[12] B. King,et al. Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist. , 2015, Pediatric neurology.
[13] Sun-Mee Lee,et al. Melatonin Inhibits mTOR-Dependent Autophagy during Liver Ischemia/Reperfusion , 2014, Cellular Physiology and Biochemistry.
[14] D. Krueger. Management of CNS-related Disease Manifestations in Patients With Tuberous Sclerosis Complex , 2013, Current Treatment Options in Neurology.
[15] C. Galluccio,et al. Application of the sleep disturbance scale for children (SDSC) in preschool age. , 2013, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[16] G. Stores. Aspects of sleep disorders in children and adolescents , 2009, Dialogues in clinical neuroscience.
[17] J. Osborne,et al. Effect of Melatonin Dosage on Sleep Disorder in Tuberous Sclerosis Complex , 2005, Journal of child neurology.
[18] O. Bruni,et al. Sleep disorders in children with neurologic diseases. , 2001, Seminars in pediatric neurology.
[19] J. Osborne,et al. Use of melatonin to treat sleep disorders in tuberous sclerosis , 1999, Developmental medicine and child neurology.
[20] O. Bruni,et al. The Sleep Disturbance Scale for Children (SDSC) Construct ion and validation of an instrument to evaluate sleep disturbances in childhood and adolescence , 1996, Journal of sleep research.
[21] O. Bruni,et al. Sleep disorders in tuberous sclerosis: a polysomnographic study , 1995, Brain and Development.
[22] G. Stores,et al. SLEEP DISORDER AND EPILEPSY IN CHILDREN WITH TUBEROUS SCLEROSIS: A QUESTIONNAIRE‐BASED STUDY , 1994, Developmental medicine and child neurology.
[23] A. Hunt. Development, behaviour and seizures in 300 cases of tuberous sclerosis. , 2008, Journal of intellectual disability research : JIDR.
[24] J. Osborne,et al. Epidemiology of Tuberous Sclerosis , 1991, Annals of the New York Academy of Sciences.
[25] A. Korczyn,et al. [Sleep disturbances]. , 2017, Harefuah.